{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-025417","form_type":"8-K","ticker":"APYX","cik":"0000719135","company_name":"Apyx Medical Corp","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.219326+00:00","generated_at":"2026-05-17T18:37:00.815596+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Apyx Medical Q2 revenue $11.4M, net loss $3.8M; raises FY2025 revenue guidance to $50-52M","bullets":["Q2 total revenue $11.4M vs $12.1M YoY; Advanced Energy flat at $9.7M, OEM down 28.5% to $1.7M.","Net loss attributable to stockholders $3.8M ($0.09/shr) vs $6.6M ($0.19/shr) YoY; adjusted EBITDA loss $2.0M vs $4.3M.","Soft launch of AYON Body Contouring System exceeding expectations; commercial launch planned September 2025.","Renuvion launched in China via partner GlamMoon; initial procedures completed with strong clinical interest.","FY2025 revenue guidance raised to $50-52M (from $47.6-49M); Advanced Energy guidance $42-44M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-025417","json":"https://secwatch.observer/filing/0001437749-25-025417.json","markdown":"https://secwatch.observer/filing/0001437749-25-025417.md","text":"https://secwatch.observer/filing/0001437749-25-025417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/719135/000143774925025417/0001437749-25-025417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/719135/000143774925025417/apyx20250526_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T18:37:00.815596+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}